SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Scripps Health will lay off 69 employees from its human resources and marketing departments this summer, according to the hospital’s president and CEO Chris Van Gorder.
Cidara Therapeutics, a clinical-stage biotech working on potential anti-fungal medications, announced financial results Friday for the fourth quarter and full 2015 year.
Tri-City Medical Center has appointed a new permanent CEO, without addressing what will happen to the old one.
Washington D.C.-based Biotechnology Innovation Organization (BIO), the largest biotech trade group in the world, has named La Jolla geneticist J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology.
Sharp Grossmont Hospital opened a new laboratory and pharmacy this month, the first phase of a $60 million renovation project at the La Mesa hospital.
Therapeutics Solutions International Inc., an Oceanside-based company developing treatments for cancer and other diseases, announced Wednesday that Dr. Hong Ma has been appointed as chief scientific officer.
La Jolla drugmaker Ligand Pharmaceuticals has earned a $6 million milestone payment from Irvine-based partner company Spectrum Pharmaceuticals.
San Diego drugmaker Orexigen Therapeutics Inc. bought the U.S. rights to its flagship obesity drug from co-developer Takeda Pharmaceuticals and said it would enlist Valeant Pharmaceuticals International to sell the pill in Europe.
Oceanside’s Tri-City Medical Center may soon part ways with CEO Tim Moran less than two years after hiring him.
Three San Diego life science firms reported earnings for the fourth quarter and the full year of 2015: Mast Therapeutics Inc., Biocept Inc. and Mirati Therapeutics Inc.
San Diego biotech Aspyrian Therapeutics has raised $40 million to pursue a new way to fight cancer.
Boston-based Vertex Pharmaceuticals is expanding its presence in San Diego.
Local health tech guru Dr. Joe Smith has been appointed the permanent CEO of Reflexion Health, a digital health company in downtown San Diego.
PHARMA: Otonomy Cuts Usual Costs, Time With Middle Ear Drug
Local drugmaker Otonomy Inc. launched its lead drug Otiprio this month, bringing the asset from the lab to market in less than eight years and without the help of Big Pharma.
TECH: CEO Steps Down; Co. in Sequencing Top Spot
Following a string of big news since the first of the year, San Diego’s Illumina Inc. announced a shakeup at headquarters — CEO Jay Flatley is stepping down.